Read by QxMD icon Read


Younes Boudjemline
No abstract text is available yet for this article.
July 10, 2018: EuroIntervention
Patrick W Serruys, Rodrigo Modolo, Michael Reardon, Yosuke Miyazaki, Stephan Windecker, Jeffrey Popma, Yanping Chang, Neal S Kleiman, Scott Lilly, Hafid Amrane, Piet W Boonstra, Arie Pieter Kappetein, Yoshinobu Onuma, Lars Sondegaard, Nicolas van Mieghem
AIMS: The indication for transcatheter valve implantation (TAVI) has evolved from inoperable patients to patients at increased surgical risk. In low risk patients, surgical aortic valve replacement (SAVR) remains the standard of care. To explore the outcomes of TAVI and SAVR in patients with a Society of Thoracic Surgery (STS) predicted risk of mortality (PROM) score below 3% in the SURTAVI trial. METHODS AND RESULTS: In SURTAVI, patients at intermediate surgical risk based on heart team consensus were randomized to TAVI or SAVR...
July 10, 2018: EuroIntervention
Hsiang-Yao Chen, Dai-Yin Lu, Shih-Hsien Sung
No abstract text is available yet for this article.
July 10, 2018: EuroIntervention
Julian Daniel Widder, Bernardo Cortese, Sebastien Levesque, Dominik Berliner, Simon Eccleshall, Kristof Graf, Luc Doutrelant, Javed Ahmed, Erwan Bressollette, Dennis Zavalloni, Davide Piraino, Ariel Roguin, Bruno Scheller, Pieter R Stella, Johann Bauersachs
AIMS: To investigate the use of drug-coated balloon (DCB) in daily clinical practice and provide further evidence for safety and efficacy of paclitaxel-coated balloon treatment using urea as inert excipient. METHODS AND RESULTS: Between December 2013 and December 2015, 757 patients treated for coronary lesions with the IN.PACT Falcon balloon were enrolled in this prospective real-world all comers registry. Primary outcome was clinically driven target lesion revascularization (TLR) rate at 12 months...
July 10, 2018: EuroIntervention
Lucas Lauder, Sebastian Ewen, Michel Azizi, Laura Mauri, Philipp Lurz, Melvin David Lobo, Faisal Sharif, William Wijns, Costas Tsioufis, Felix Mahfoud
No abstract text is available yet for this article.
July 4, 2018: EuroIntervention
Sebastian Ewen, Lucas Lauder, Michel Azizi, David E Kandzari, Atul Pathak, Faisal Sharif, William Wijns, Felix Mahfoud, Thomas F Lüscher
No abstract text is available yet for this article.
July 4, 2018: EuroIntervention
Fernando Rivero, Esther González-Bartol, Javier Cuesta, Fernando Alfonso
No abstract text is available yet for this article.
July 3, 2018: EuroIntervention
Stefan Toggweiler, Bart De Boeck, Miriam Brinkert, Ralf Buhmann, Matthias Bossard, Richard Kobza, Florim Cuculi
Here we describe the first implantation of the novel bicavally anchored Tricento® transcatheter heart valve via transvenous transfemoral access in a 74-year-old woman with severe tricuspid regurgitation and holosystolic hepatic vein backflow. Following successful implantation, caval vein regurgitant volume was reduced leading to symptomatic and clinical improvement at 3 months follow-up. The Tricento® device represents a promising, novel therapeutic option for patients with severe tricuspid regurgitation that are not candidates for open heart surgery...
July 3, 2018: EuroIntervention
Yuki Katagiri, Patrick W Serruys, Erhan Tenekecioglu, Taku Asano, Carlos Collet, Yosuke Miyazaki, Athanasios Katsikis, Jan J Piek, Joanna J Wykrzykowska, Bernard Chevalier, Gary S Mintz, Gregg W Stone, Yoshinobu Onuma
AIMS: To investigate relocation of minimal lumen area (MLA) after implantation of bioresorbable scaffold (BRS). METHODS AND RESULTS: In the ABSORB II randomized trial [BRS vs. everolimus-eluting stent (EES)], lesions were investigated by serial intravascular ultrasound pre-procedure, post-procedure, and at 3-year. MLA relocation was defined as an axial MLA shift of more than 2.4 mm. MLA relocation from post-procedure to 3-year was observed in 163/237 (68.8%) and 75/129 (58...
July 3, 2018: EuroIntervention
Oscar Millan-Iturbe, Ole De Backer, Gintautas Bieliauskas, Tasalak Thonghong, Manik Chopra, Nikolaj Ihlemann, Lars Søndergaard
AIMS: Transcatheter aortic valve implantation (TAVI) is an established therapy for patients with severe aortic stenosis (AS). The aim of this study was to evaluate the newer generation PorticoTM TAVI system (Abbott, MN, USA) in an all-comers population. METHODS AND RESULTS: This single-centre study included 216 patients with severe AS (Society of Thoracic Surgeons (STS) score 4.3±3.0%). The PorticoTM valve was implanted using transfemoral (91.2%), transsubclavian (5...
July 3, 2018: EuroIntervention
Jean-Philippe Collet, Mathieu Kerneis, Benoit Lattuca, Yan Yan, Guillaume Cayla, Johanne Silvain, Frédéric Lapostolle, Patrick Ecollan, Abdourahmane Diallo, Eric Vicaut, Christian W Hamm, Arnoud W Van 't Hof, Gilles Montalescot
AIMS: To examine the main results of the ATLANTIC trial in patients with ST-elevation myocardial infarction (STEMI), randomized to pre- versus in-hospital ticagrelor according to age. METHODS AND RESULTS: Patients were evaluated by age class (<75 vs. ≥75 years) for demographics, prior cardiovascular history, risk factors, management, and outcomes. Elderly patients (≥75 years; 304/1862) were more likely to be women, diabetic, lean, with a prior history of myocardial infarction and CABG, and with comorbidities (p<0...
July 3, 2018: EuroIntervention
Markus Kasel, Moritz Rumpf, Antonio H Frangieh, Patrick Mayr, Michael Joner, Erion Xhepa, Robert J Lederman, Adam B Greenbaum, Jaffar M Khan, Ilka Ott, Oliver Deutsch, Jonathan M Michel
No abstract text is available yet for this article.
July 3, 2018: EuroIntervention
Daniela Branzan, Christian D Etz, Michael Moche, Konstatin Von Aspern, Holger Staab, Jochen Fuchs, Florian Then Bergh, Dierk Scheinert, Andrej Schmidt
AIMS: The purpose of our study was to report our experience with MISACE (minimally invasive segmental artery coil embolization) to prevent spinal cord ischemia (SCI) after endovascular repair (ER) of thoraco-abdominal aortic aneurysm (TAAA). METHODS AND RESULTS: A cohort of 57 patients with TAAAs was treated by MISACE followed by ER between October 2014 and December 2017. The TAAA Crawford Classification was: type I, n= 5; type II, n=12; type III, n=27; type IV, n=13...
July 3, 2018: EuroIntervention
Piotr Scisło, Radosław Wilimski, Karol Zbroński, Zenon Huczek
No abstract text is available yet for this article.
July 3, 2018: EuroIntervention
Thomas Chollet, Bertrand Marcheix, Nicolas Boudou, Meyer Elbaz, Francisco Campelo-Parada, Vincent Bataille, Frederic Bouisset, Olivier Lairez, Jean Porterie, Michel Galinier, Didier Carrie, Thibault Lhermusier
AIMS: We aimed to compare long-term outcomes of transaortic (TAo-AVR) and transfemoral (TF-AVR) transcatheter aortic valve replacement. METHODS AND RESULTS: Consecutive TAo-AVR and TF-AVR cases between January 2012 to December 2015 were compared using a propensity score matching analysis. Primary endpoints were 30-day and 1-year mortality. 644 TAVR patients were included (163 TAo-AVR and 481 TF-AVR). Patients from the TAo-AVR group had more peripheral arterial disease (31...
July 3, 2018: EuroIntervention
Alexander Massmann, Peter Fries, Reinhard Kubale, Roland Seidel
AIMS: Ultrasound of a 59-year-old patient presenting signs of congestive heart failure and abdominal pain depicted cirrhose-cardiaque based on volume-overload related right-heart-insufficiency. Computed-tomography revealed an underlying abdominal aortic aneurysm of maximum 7.5cm combined with a large aorto-caval fistula (ACF) to the infrarenal vena cava (IVC). METHODS AND RESULTS: After urgent EVAR a large endoleak type 2 (EL2) and ACF persisted. Coil-embolization of inferior mesenteric artery was performed...
July 3, 2018: EuroIntervention
Lars Kjøller-Hansen, Niels Bligaard, Henning Kelbæk, Evald Høj Christiansen, Leif Thuesen, Peter R Hansen, Thomas Engstrøm, Anders Junker, Ulrik Abildgaard, Jens Flensted Lassen, Jan S Jensen, Jørgen L Jeppesen, Anders M Galløe
AIMS: To determine whether patients treated with drug-eluting stents in the proximal left anterior descending artery (LAD) carried a different long-term prognosis than patients treated in other coronary artery segments. METHODS AND RESULTS: 10-year clinical outcome expressed as all-cause mortality and major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, or target vessel revascularization) was determined for 1,479 patients with a single non-left main coronary stenosis treated with a first-generation drug-eluting stent in the SORT OUT II trial...
July 3, 2018: EuroIntervention
Erhan Tenekecioglu, Ryo Torii, Yuki Katagiri, Taku Asano, Rodrigo Modolo, Yosuke Miyazaki, Ply Chichareon, Eric K W Poon, Frank Gijsen, Vikas Thondapu, David van Klaveren, Hans Jonker, Andrew Ooi, Peter Barlis, Carlos Collet, Yoshinobu Onuma, Christos V Bourantas, Patrick W Serruys
AIMS: To evaluate the effect of strut protrusion(SP) on wall shear stress(WSS) and neointimal growth(NG) one and five-year after implantation of Absorb bioresorbable vascular scaffold. METHODS AND RESULTS: Eight patients were selected from the first-in-man study.Following three-dimensional(3D) reconstruction of the coronaries, WSS was quantified using Newtonian steady-flow simulation in each cross-section at 5°-subunit(sector) of the circumferential luminal surface...
July 3, 2018: EuroIntervention
Cyril Štěchovský, Petr Hájek, Martin Horváth, Josef Veselka
AIMS: Catheter-based intravascular near-infrared spectroscopy (NIRS) detects a lipid signal from atherosclerotic plaque. The aim of this study was to describe the effect of carotid artery stenting (CAS) on the lipid signal in a carotid stenosis. METHODS AND RESULTS: We performed NIRS combined with intravascular ultrasound (IVUS) during 120 CAS procedures. Minimal luminal area (MLA) and plaque burden (PB) at the site of MLA were measured with IVUS and lipid core burden index (LCBI), maximal LCBI in a 4-mm segment of the artery (LCBImax) and LCBI in a 4-mm segment at the site of MLA (LCBImla) with NIRS-derived chemograms...
June 26, 2018: EuroIntervention
Naotaka Okamoto, Hiroshi Ueda, Samit Bhatheja, Yuliya Vengrenyuk, Melissa Aquino, Samaneh Rabiei, Nitin Barman, Vishal Kapur, Choudhury Hasan, Roxana Mehran, Usman Baber, Annapoorna S Kini, Samin K Sharma
AIMS: We sought to evaluate procedural complications and 1-year clinical outcomes for patients who underwent percutaneous coronary intervention (PCI) with orbital (OA) and rotational atherectomy (RA). METHODS AND RESULTS: From a total of 13,467 patients who underwent PCI in our hospital between January 2013 and June 2016, 1149 consecutive patients were treated with atherectomy for moderately-severely calcified lesions (184 with OA, 965 with RA). Procedural complications were similarly observed in 2 groups except for higher dissection and perforation rates with OA...
June 26, 2018: EuroIntervention
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"